课题基金 / 基金详情

REGULATED FIV VECTORS FOR VACCINATION

REGULATED FIV VECTORS FOR VACCINATION
用于疫苗接种的管制五种载体
批准号:
6021268
负责人:
Ellen Elizabeth Sparger
金额:
$14.6万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-09-01 至 2001-08-31

项目摘要

项目成果

Ellen Elizabeth Sparger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from Applicant's Abstract) Infection of cats with the feline immunodeficiency virus (FIV) produces an immunodeficiency syndrome with pathogenesis very similar to that observed in people infected with human immunodeficiency virus type 1 (HIV-1). FIV replicates primarily in CD4+ T cells and macrophages in vivo and produces progressive CD4+ T cell depletion that eventually renders the host susceptible to opportunistic infection. FIV also shares several genetic similarities with HIV and therefore provides an animal model for evaluating viral determinants of pathogenesis. The investigators have characterized FIV long terminal repeat (LTR) mutants and a vif-deletion mutant. The latter has been used as an attenuated virus that was capable of inducing protective immunity against infection with wild type FIV in vaccinated cats. For this proposal, the investigators hypothesize that molecular clones of FIV, attenuated for virulence, can be genetically engineered for regulated viral gene expression. Such FIV clones, physiologically regulated by administration of tetracycline (tet) to cats, will be tested as live-attenuated virus vaccines aimed at prevent infection with pathogenic challenge virus. This approach will make it feasible to examine the relationship of viral "threshold" level, protective immunity, and vaccine safety in cats inoculated with tet-regulated FIV clones. Most importantly, these experiments will test the usefulness of this approach of tet-regulated attenuated virus expression as a mechanism for increasing the safety of attenuated lentiviral vaccines. The investigators have also demonstrated that infection can be established in cats inoculated with plasmids containing the FIV provirus and that protective immunity against wild type FIV infection may be induced in cats inoculated with vif-deleted proviral DNA. Accordingly, "naked viral DNA" injection will be tested as a delivery system for infection of cats with tet-regulated attenuated FIV isolates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
GMP production and GLP safety of bidirectionally targeted SARS-CoV-2 booster vaccine
  • 批准号:
    10766657
  • 项目类别:
  • 资助金额:
    $100.0万
  • 财政年份:
    2023
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
HIGHLY ATTENUATED SIV VIF DNA VACCINES
  • 批准号:
    7959001
  • 项目类别:
  • 资助金额:
    $14.66万
  • 财政年份:
    2009
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
HIGHLY ATTENUATED SIV VIF DNA VACCINES
  • 批准号:
    7715581
  • 项目类别:
  • 资助金额:
    $16.9万
  • 财政年份:
    2008
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
Cellular Immune Responses Induced by SIVdelta-vif plus IL-15 DNA Vaccine
  • 批准号:
    7494904
  • 项目类别:
  • 资助金额:
    $7.6万
  • 财政年份:
    2008
  • 负责人:
    Ellen Elizabeth Sparger
  • 依托单位:
国内基金
海外基金
CatS介导的HDAC6信号通路在慢性应激性血管内膜增生中的作用及分子机制
  • 批准号:
    82060052
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    33.0万元
  • 批准年份:
    2020
  • 负责人:
    李香
  • 依托单位:
猪12号染色体上新基因的CATS法分离及其定位和效应研究
  • 批准号:
    39870594
  • 项目类别:
    面上项目
  • 资助金额:
    16.0万元
  • 批准年份:
    1998
  • 负责人:
    李奎
  • 依托单位: